Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 2 1

Status

Recruiting 185Active not recruiting 73Not yet recruiting 45Completed 43Terminated 10Suspended 5Enrolling by invitation 4Withdrawn 3Available 3

Sponsor Class

OTHER 2INDUSTRY 1

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 3

Conditions

Neoplasms 10Prostatic Neoplasms 7Lung Neoplasms 6Recurrence 4Multiple Myeloma 4Lymphoma, B-Cell 4Lymphoma 4Colorectal Neoplasms 4Breast Neoplasms 4Urinary Bladder Neoplasms 3Precursor Cell Lymphoblastic Leukemia-Lymphoma 3Pancreatic Neoplasms 3Ovarian Neoplasms 3Head and Neck Neoplasms 3Urologic Neoplasms 2Solid Tumor 2Small Cell Lung Carcinoma 2Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2Non-Muscle Invasive Bladder Neoplasms 2Neoplasm Metastasis 2Melanoma 2Lymphoma, Follicular 2Leukemia, Myeloid, Acute 2Leukemia 2Glioblastoma 2Cholangiocarcinoma 2Carcinoma, Renal Cell 2Vasculitis 1Uterine Cervical Neoplasms 1Urogenital Neoplasms 1

Interventions

Gemcitabine 1Capecitabine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Withdrawn × Pancreatic Neoplasms × 90 days × Clear all
NCT05415917 2026-05-07

Adjuvant Gemcitabine and Capecitabine Chemotherapy in Resected Pancreatic Cancer Following Neoadjuvant Chemotherapy

Rutgers, The State University of New Jersey

Phase 2 Withdrawn
Gastrointestinal

Pancreatic Neoplasms

NCT02872831 2026-04-13

Beacon BNXâ„¢ Endoscopic Ultrasound (EUS)-Needle vs SharkCoreâ„¢ Needle

Thomas Jefferson University

Phase NA Withdrawn
Gastrointestinal

Lymphadenopathy, Pancreatic Neoplasms, Cholangiocarcinoma

NCT05188573 2026-03-27

EpiDetect Study: Clinical Validation of a Pancreatic Cancer Detection Test in New-Onset Diabetes Patients

ClearNote Health

Phase NA Withdrawn
Gastrointestinal

Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡